Company intelligence / Profile preview

BioFabbrica

Costa Masnaga, Lombardy, Italy

Ownership: Private
Development stage: Other

Overview

BioFabbrica is a joint venture formed by Limonta and Modern Meadow to commercialize bio-based, animal-free performance materials rather than human therapeutics or healthcare products. The company combines Limonta's textile manufacturing and finishing capabilities with Modern Meadow's biofabrication technology to produce coated materials for fashion, footwear, automotive, interiors, and related applications. Its best-known product family is Bio-Tex, a bio-based coated textile positioned as an alternative to conventional leather and synthetic materials. Based on available public information, BioFabbrica operates as a commercial biomaterials company and is not a life science, biotech therapeutics, pharma, or healthcare company in the drug-development sense.

Industry: Non-Drug Biotech

Partnerships

Limonta/Modern Meadow

Beyond the preview

Go deeper on BioFabbrica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioFabbrica.

Explore the full profile